Non disponible en dehors du Royaume-Uni et de l'Irlande
General description
A highly selective agonist of adenosine A3 receptor (Ki = 330 pM)
An adenosine analog that acts as a highly selective agonist of adenosine A3 receptor (Ki = 330 pM, 820 nM, 470 nM for A3, A1 and A2A, respectively). Shown to reduce ischemia reperfusion injury in mice and limit infarct size in isolated rat hearts. Shown to reversibly increase field excitatory postsynaptic potentials in hippocampal slices and exhibits excitatory effects on both evoked and spontaneous epileptiform discharges.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Kim, H. O., et al. 1994. J Med Chem.37, 3614.Laudadio, M. A., et al. 2004. Epilepsy Res.59, 83.Ge, Z.D., et al. 2006. J. Pharm. Exp. Ther.319, 1200.
Packaging
Packaged under inert gas
2 mg in Glass bottle
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Warning
Toxicity: Standard Handling (A)
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :